Cleared Traditional

K002424 - 3D ANGIOGRAPHIC IMAGING SYSTEM

K002424 is the FDA 510(k) clearance for 3D ANGIOGRAPHIC IMAGING SYSTEM by Toshiba America Medical Systems, In.C. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 80-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2000
Decision
80d
Days
Class 2
Risk

K002424 is an FDA 510(k) clearance for the 3D ANGIOGRAPHIC IMAGING SYSTEM, MODEL XIDF-100A. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Toshiba America Medical Systems, In.C (Tustin, US). The FDA issued a Cleared decision on October 27, 2000 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Toshiba America Medical Systems, In.C devices

Submission Details

510(k) Number K002424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 2000
Decision Date October 27, 2000
Days to Decision 80 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d faster than avg
Panel avg: 107d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K002424.
ODYSSEY LX, MODEL 211320
K003437 · Philips Medical Systems (Cleveland), Inc. · Feb 2001
PHILIPS EASY VISION FAMILY WORKSTATION OPTION MR QUANTITATIVE FLOW
K003459 · Philips Medical Systems North America, Inc. · Jan 2001
PHILIPS EASY VISION FAMILY WORKSTATION OPTION CARDIRAC SCORING
K002942 · Philips Medical Systems North America, Inc. · Dec 2000
VITREA 2, VERSION 2.1
K002519 · Vital Images, Inc. · Oct 2000
MEDLINK DIAGNOSTIC OFFLINE WORKSTATION
K002144 · Advanced Technology Laboratories, Inc. · Sep 2000
BARCO MWD 321 PLUS MEDICAL WORKSTATION DISPLAY
K000292 · Barco N.V. · Mar 2000